FDA: Montelukast Tablet Bottles Recalled

Share this content:
FDA: Montelukast Tablet Bottles Recalled
FDA: Montelukast Tablet Bottles Recalled

TUESDAY, Sept. 4, 2018 (HealthDay News) -- Some bottles of montelukast (Singulair) tablets for asthma have been recalled by Camber Pharmaceuticals because they contain the wrong medication, the U.S. Food and Drug Administration says.

Bottles labeled as containing 30 tablets of 10-milligram montelukast sodium tablets instead contain 90 tablets of losartan potassium tablets.

There is a safety risk because taking losartan when not prescribed can cause renal dysfunction, elevated potassium levels, and low blood pressure. The risk can be especially high for pregnant woman because losartan could harm or kill the fetus, the FDA said Friday.

The recalled bottles have the following lot numbers: MON17384, expiration date: 12/31/2019, and NDC: 31722-726-30. Patients who have the recalled bottles should contact their health care provider or pharmacist immediately, the FDA said.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Progress in HIV Prevention Has Stalled in the United States

CDC: Progress in HIV Prevention Has Stalled in ...

Agency says effective HIV prevention, treatment not reaching those who could most benefit

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in Children

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in ...

All children with sustained unresponsiveness ingested concentrated and baked egg

Prenatal Vitamin Intake in Early Pregnancy May Cut Autism Risk

Prenatal Vitamin Intake in Early Pregnancy May Cut ...

ASD risk down for children whose mothers took prenatal vitamins during first month of pregnancy

is free, fast, and customized just for you!




Already a member?

Sign In Now »